We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Aussie Drugmakers Want Higher Orphan Drug Threshold
Aussie Drugmakers Want Higher Orphan Drug Threshold
Drugmakers in Australia are urging the Therapeutic Goods Administration to raise the number of patients required for classifying an orphan disease, saying it would bring the threshold in line with the EU, Canada and Switzerland.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor